Cover Image
市場調查報告書

印尼的醫藥品、醫療產業(季度更新報告)

Indonesia Pharmaceuticals & Healthcare Q4 2018

出版商 BMI Research 商品編碼 177846
出版日期 內容資訊 英文 88 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
印尼的醫藥品、醫療產業(季度更新報告) Indonesia Pharmaceuticals & Healthcare Q4 2018
出版日期: 2018年09月18日 內容資訊: 英文 88 Pages
簡介

本報告提供印尼的製藥、醫療產業結構和最新趨勢相關分析,今後10年的產業規模的動向估計,產業的課題(風險)和未來商機(利潤)相關評估,政府的政策、規定,宏觀經濟環境,主要企業簡介等資訊彙整,為您概述為以下內容。

BMI的見解

SWOT分析

產業預測

  • 醫藥品市場預測
  • 醫療市場預測
  • 處方藥市場預測
  • 專利藥市場預測
  • 學名藥市場預測
  • 成藥市場預測
  • 醫藥品的對外貿易情形

產業的風險/利潤、等級

  • 亞太地區:風險/利潤、等級
  • 印尼:風險/利潤、等級
    • 利潤
    • 風險

法規的檢討

  • 智慧財產權相關課題
  • 藥價
  • 償付

產業的趨勢與發展

  • 市場概要
  • 醫療部門
  • 研究開發
  • 臨床實驗
  • 流行病學

競爭情形

  • 研究開發
  • 學名藥
  • 醫藥品的流通部門
  • 醫藥品的零售部門

企業簡介

人口動態的預測

  • 人口動態預測

詞彙表

調查手法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: SSID03_20181001

Key View:

We do not expect Indonesia to achieve its goal of having universal healthcare by 2019. While significant progress has

been made in growing enrolment into the national health insurance scheme (JKN), further expansion will be hampered by deficit,

investment shortages and uneven levels of healthcare access across the country. Additionally, for the pharmaceutical industry, the

JKN's positive impact on growth is likely to wane over the medium term, as the scheme focuses on sales of low-cost generic drugs.

Still, Indonesia's substantial population numbers, its epidemiological profile the emerging middle class will continue to offer

significant commercial opportunities for multinationals.

Table of Contents

  • Key View
  • SWOT
  • Industry Forecast
  • Pharmaceutical Market Forecast
  • Healthcare Market Forecast
  • Prescription Drug Market Forecast
  • Patented Drug Market Forecast
  • Generic Drug Market Forecast
  • OTC Medicine Market Forecast
  • Pharmaceutical Trade Forecast
  • Industry Risk/Reward Index
  • Asia Pacific Innovative Pharmaceuticals & Healthcare Risk/Reward Index
  • Indonesia Innovative Pharmaceuticals Risk/Reward Index
  • Regulatory Development
  • Regulatory Review
  • Industry Trends And Developments
  • Market Overview

Competitive Landscape

  • Company Profile
  • Bayer
  • Darya-Varia Group
  • GlaxoSmithKline
  • Indofarma
  • Kimia Farma
  • Merck & Co
  • Merck Group
  • Novartis
  • Pfizer
  • PT Bio Farma
  • PT Kalbe Farma
  • Sanofi
  • Soho Global Healthcare Group
  • Indonesia Demographic Outlook
  • Pharmaceuticals & Healthcare Glossary
  • Pharmaceuticals & Healthcare Methodology
Back to Top